| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Diseases | 4 | 2025 | 146 | 2.390 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2026 | 331 | 1.790 |
Why?
|
| Neurodevelopmental Disorders | 7 | 2024 | 624 | 1.650 |
Why?
|
| Ischemia | 3 | 2025 | 358 | 1.590 |
Why?
|
| Intellectual Disability | 6 | 2024 | 1080 | 1.330 |
Why?
|
| Megalencephaly | 2 | 2023 | 59 | 1.320 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 8 | 2013 | 284 | 1.220 |
Why?
|
| Reperfusion Injury | 2 | 2025 | 110 | 0.980 |
Why?
|
| Neuroprotective Agents | 2 | 2025 | 162 | 0.940 |
Why?
|
| Monoterpenes | 1 | 2025 | 8 | 0.940 |
Why?
|
| Iridoid Glucosides | 1 | 2025 | 5 | 0.910 |
Why?
|
| Angiopoietin-2 | 1 | 2025 | 12 | 0.910 |
Why?
|
| Glucosides | 1 | 2025 | 54 | 0.900 |
Why?
|
| Chromothripsis | 1 | 2025 | 8 | 0.890 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2026 | 113 | 0.880 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2025 | 89 | 0.870 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2025 | 107 | 0.850 |
Why?
|
| Zinc Fingers | 2 | 2022 | 116 | 0.830 |
Why?
|
| beta Catenin | 1 | 2025 | 198 | 0.810 |
Why?
|
| Glaucoma | 1 | 2024 | 88 | 0.760 |
Why?
|
| Antioxidants | 1 | 2025 | 334 | 0.750 |
Why?
|
| Microcephaly | 2 | 2022 | 348 | 0.730 |
Why?
|
| Drosophila | 5 | 2024 | 774 | 0.720 |
Why?
|
| Epilepsy | 3 | 2024 | 862 | 0.690 |
Why?
|
| Drosophila Proteins | 3 | 2024 | 776 | 0.690 |
Why?
|
| Transcription Factors | 3 | 2022 | 2423 | 0.640 |
Why?
|
| Hydrocephalus | 1 | 2023 | 275 | 0.630 |
Why?
|
| Rats, Wistar | 3 | 2025 | 301 | 0.630 |
Why?
|
| Mutation | 5 | 2019 | 6085 | 0.610 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 445 | 0.610 |
Why?
|
| Pigmentation Disorders | 1 | 2018 | 22 | 0.580 |
Why?
|
| Malformations of Cortical Development | 1 | 2018 | 60 | 0.560 |
Why?
|
| Rats | 6 | 2025 | 3374 | 0.500 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 130 | 0.490 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 430 | 0.480 |
Why?
|
| Neurons | 10 | 2024 | 2001 | 0.460 |
Why?
|
| Zebrafish | 2 | 2017 | 417 | 0.450 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2026 | 93 | 0.450 |
Why?
|
| Animals | 28 | 2025 | 33773 | 0.450 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 287 | 0.410 |
Why?
|
| Autistic Disorder | 2 | 2022 | 395 | 0.390 |
Why?
|
| Cell Survival | 2 | 2025 | 829 | 0.390 |
Why?
|
| Glutamic Acid | 3 | 2014 | 193 | 0.360 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 24 | 0.360 |
Why?
|
| Threonine | 1 | 2012 | 62 | 0.360 |
Why?
|
| Biomedical Research | 1 | 2017 | 561 | 0.330 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2010 | 13 | 0.330 |
Why?
|
| Rett Syndrome | 2 | 2010 | 229 | 0.330 |
Why?
|
| Chromosome Deletion | 3 | 2025 | 652 | 0.330 |
Why?
|
| Muscle Hypotonia | 3 | 2022 | 194 | 0.330 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 4660 | 0.320 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2021 | 468 | 0.320 |
Why?
|
| DNA Copy Number Variations | 4 | 2025 | 1022 | 0.310 |
Why?
|
| Male | 22 | 2026 | 64344 | 0.310 |
Why?
|
| Haploinsufficiency | 4 | 2020 | 264 | 0.310 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 175 | 0.310 |
Why?
|
| Nervous System Malformations | 2 | 2022 | 136 | 0.300 |
Why?
|
| Humans | 33 | 2026 | 130241 | 0.290 |
Why?
|
| Synapses | 2 | 2014 | 443 | 0.280 |
Why?
|
| Mutation, Missense | 3 | 2024 | 922 | 0.280 |
Why?
|
| Fibroblasts | 2 | 2024 | 852 | 0.280 |
Why?
|
| Alleles | 3 | 2024 | 1677 | 0.270 |
Why?
|
| Whole Genome Sequencing | 3 | 2025 | 360 | 0.270 |
Why?
|
| Exons | 2 | 2022 | 761 | 0.260 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2007 | 101 | 0.260 |
Why?
|
| Brain Diseases | 2 | 2020 | 298 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 4 | 2024 | 1081 | 0.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 584 | 0.250 |
Why?
|
| Child, Preschool | 9 | 2025 | 14933 | 0.240 |
Why?
|
| Phenotype | 6 | 2022 | 4465 | 0.240 |
Why?
|
| Ranibizumab | 1 | 2026 | 12 | 0.240 |
Why?
|
| Glycosides | 1 | 2025 | 10 | 0.240 |
Why?
|
| Genome, Human | 3 | 2024 | 1313 | 0.230 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 1946 | 0.230 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2025 | 31 | 0.230 |
Why?
|
| Photochemotherapy | 1 | 2026 | 40 | 0.230 |
Why?
|
| Wnt Signaling Pathway | 2 | 2025 | 208 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2025 | 109 | 0.220 |
Why?
|
| MEF2 Transcription Factors | 1 | 2025 | 34 | 0.220 |
Why?
|
| Syndrome | 4 | 2025 | 1159 | 0.220 |
Why?
|
| Chromosome Inversion | 1 | 2024 | 70 | 0.210 |
Why?
|
| Essential Hypertension | 1 | 2024 | 12 | 0.210 |
Why?
|
| Pedigree | 3 | 2024 | 1672 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2024 | 76 | 0.200 |
Why?
|
| Retinal Ganglion Cells | 1 | 2025 | 115 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 103 | 0.200 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 58 | 0.200 |
Why?
|
| Female | 18 | 2026 | 70257 | 0.200 |
Why?
|
| Chromosome Disorders | 1 | 2025 | 317 | 0.200 |
Why?
|
| Hydrogen Peroxide | 1 | 2024 | 116 | 0.200 |
Why?
|
| Cysteine | 1 | 2024 | 137 | 0.200 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2025 | 743 | 0.190 |
Why?
|
| Quadriplegia | 1 | 2023 | 34 | 0.190 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 775 | 0.190 |
Why?
|
| Down-Regulation | 1 | 2025 | 648 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 1 | 2024 | 260 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 245 | 0.190 |
Why?
|
| Drosophila melanogaster | 4 | 2022 | 837 | 0.190 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 327 | 0.190 |
Why?
|
| Visual Acuity | 1 | 2026 | 531 | 0.190 |
Why?
|
| p21-Activated Kinases | 1 | 2023 | 57 | 0.190 |
Why?
|
| Mice | 14 | 2025 | 18190 | 0.180 |
Why?
|
| Combined Modality Therapy | 1 | 2026 | 1216 | 0.180 |
Why?
|
| Synaptic Transmission | 4 | 2020 | 314 | 0.180 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 16 | 0.180 |
Why?
|
| Epileptic Syndromes | 1 | 2022 | 35 | 0.180 |
Why?
|
| Cell Line | 2 | 2025 | 2560 | 0.180 |
Why?
|
| Histidine | 1 | 2022 | 69 | 0.180 |
Why?
|
| Protein Domains | 1 | 2023 | 252 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2020 | 1541 | 0.180 |
Why?
|
| Retina | 1 | 2025 | 440 | 0.180 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 98 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2024 | 299 | 0.170 |
Why?
|
| Protein Kinases | 1 | 2023 | 315 | 0.170 |
Why?
|
| Memory | 1 | 2024 | 354 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 410 | 0.170 |
Why?
|
| Zika Virus | 1 | 2022 | 151 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 536 | 0.160 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 165 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2025 | 795 | 0.160 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 174 | 0.160 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 20 | 0.160 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 35 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 82 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 617 | 0.150 |
Why?
|
| Epilepsy, Generalized | 1 | 2020 | 61 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 62 | 0.150 |
Why?
|
| Genotype | 2 | 2018 | 2590 | 0.150 |
Why?
|
| Ataxia | 2 | 2020 | 157 | 0.150 |
Why?
|
| Rare Diseases | 2 | 2020 | 206 | 0.150 |
Why?
|
| SNARE Proteins | 2 | 2010 | 20 | 0.150 |
Why?
|
| Apoptosis | 1 | 2025 | 1829 | 0.150 |
Why?
|
| Genes | 1 | 2019 | 308 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 219 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2010 | 4672 | 0.140 |
Why?
|
| Choroid Diseases | 1 | 2018 | 17 | 0.140 |
Why?
|
| Exome | 5 | 2024 | 1066 | 0.140 |
Why?
|
| Child | 8 | 2024 | 26071 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 8 | 0.130 |
Why?
|
| Skin | 1 | 2021 | 536 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2024 | 1074 | 0.130 |
Why?
|
| Hippocampus | 4 | 2014 | 783 | 0.130 |
Why?
|
| Social Networking | 1 | 2017 | 14 | 0.130 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 404 | 0.130 |
Why?
|
| Urogenital Abnormalities | 1 | 2019 | 158 | 0.130 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 31 | 0.130 |
Why?
|
| Genitalia | 1 | 2016 | 39 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2018 | 110 | 0.130 |
Why?
|
| Mosaicism | 1 | 2018 | 248 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2016 | 46 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 147 | 0.120 |
Why?
|
| Retinal Telangiectasis | 1 | 2016 | 2 | 0.120 |
Why?
|
| Biomarkers | 1 | 2026 | 3380 | 0.120 |
Why?
|
| Infant | 6 | 2024 | 13223 | 0.120 |
Why?
|
| Adolescent | 6 | 2024 | 20706 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 102 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2016 | 274 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 195 | 0.110 |
Why?
|
| Neurogenesis | 2 | 2014 | 211 | 0.110 |
Why?
|
| Patient Participation | 1 | 2017 | 247 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 45 | 0.100 |
Why?
|
| Mice, Knockout | 6 | 2020 | 3821 | 0.100 |
Why?
|
| Reflex, Startle | 2 | 2010 | 34 | 0.100 |
Why?
|
| Dendritic Spines | 1 | 2013 | 56 | 0.100 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 67 | 0.100 |
Why?
|
| Presynaptic Terminals | 2 | 2010 | 79 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2010 | 49 | 0.090 |
Why?
|
| Synaptic Vesicles | 2 | 2010 | 68 | 0.090 |
Why?
|
| Dendrites | 1 | 2013 | 184 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 562 | 0.090 |
Why?
|
| Software | 1 | 2017 | 731 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2024 | 8517 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 2330 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2014 | 2897 | 0.090 |
Why?
|
| Genomics | 1 | 2019 | 1612 | 0.090 |
Why?
|
| Survival Rate | 2 | 2020 | 2109 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2026 | 17497 | 0.080 |
Why?
|
| Nerve Net | 1 | 2014 | 256 | 0.080 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2010 | 17 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 964 | 0.080 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2010 | 29 | 0.080 |
Why?
|
| Adult | 5 | 2024 | 31092 | 0.080 |
Why?
|
| Psychomotor Disorders | 1 | 2010 | 30 | 0.080 |
Why?
|
| Protein Binding | 3 | 2010 | 1657 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 44 | 0.080 |
Why?
|
| Compulsive Behavior | 1 | 2010 | 45 | 0.080 |
Why?
|
| Long-Term Potentiation | 1 | 2010 | 106 | 0.080 |
Why?
|
| Respiration | 1 | 2010 | 119 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 1694 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2007 | 272 | 0.080 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2009 | 28 | 0.080 |
Why?
|
| Homovanillic Acid | 1 | 2009 | 30 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2026 | 12827 | 0.080 |
Why?
|
| Neural Inhibition | 1 | 2010 | 109 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 809 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2010 | 66 | 0.080 |
Why?
|
| Amines | 1 | 2009 | 35 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2822 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 47 | 0.080 |
Why?
|
| Genetic Testing | 3 | 2024 | 1098 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2024 | 488 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 80 | 0.070 |
Why?
|
| Aged | 2 | 2026 | 20837 | 0.070 |
Why?
|
| Phosphoserine | 1 | 2009 | 38 | 0.070 |
Why?
|
| Rhombencephalon | 1 | 2009 | 64 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2014 | 1015 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 89 | 0.070 |
Why?
|
| Appetite Regulation | 1 | 2008 | 40 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 292 | 0.070 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2007 | 6 | 0.070 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2007 | 15 | 0.070 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 18 | 0.070 |
Why?
|
| Middle Aged | 2 | 2026 | 28334 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2007 | 93 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 235 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3745 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2008 | 199 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2007 | 237 | 0.060 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 136 | 0.060 |
Why?
|
| Brain | 3 | 2022 | 3160 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2010 | 846 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 3396 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2017 | 1590 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2019 | 500 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 2400 | 0.060 |
Why?
|
| Chromatin | 1 | 2009 | 501 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2009 | 1573 | 0.060 |
Why?
|
| Learning | 2 | 2024 | 368 | 0.060 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2024 | 9 | 0.050 |
Why?
|
| Pan troglodytes | 1 | 2024 | 68 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 44 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2008 | 760 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1384 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2008 | 539 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 966 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2022 | 9 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 9990 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2025 | 5046 | 0.050 |
Why?
|
| Age of Onset | 1 | 2024 | 595 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2009 | 899 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 159 | 0.040 |
Why?
|
| Body Weight | 2 | 2020 | 984 | 0.040 |
Why?
|
| Age Factors | 1 | 2007 | 2825 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2020 | 12 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2020 | 72 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 393 | 0.040 |
Why?
|
| Hindlimb | 1 | 2020 | 72 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2020 | 91 | 0.040 |
Why?
|
| Nephrons | 1 | 2019 | 17 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2019 | 112 | 0.040 |
Why?
|
| Synaptotagmin I | 2 | 2010 | 9 | 0.040 |
Why?
|
| Urinary Tract | 1 | 2019 | 54 | 0.040 |
Why?
|
| Anxiety | 2 | 2020 | 1007 | 0.030 |
Why?
|
| Homozygote | 1 | 2020 | 535 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 4709 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 1218 | 0.030 |
Why?
|
| White Matter | 1 | 2020 | 215 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 720 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2018 | 76 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2890 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1112 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2553 | 0.030 |
Why?
|
| Social Behavior | 2 | 2008 | 210 | 0.030 |
Why?
|
| Taiwan | 1 | 2016 | 38 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2016 | 30 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2020 | 554 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 204 | 0.030 |
Why?
|
| Seizures | 1 | 2020 | 874 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2016 | 225 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 3473 | 0.030 |
Why?
|
| Calcium | 2 | 2010 | 1028 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 54 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 450 | 0.020 |
Why?
|
| Kidney | 1 | 2019 | 1277 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 1660 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 42 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2009 | 46 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2009 | 32 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 24 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3790 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 364 | 0.020 |
Why?
|
| Nesting Behavior | 1 | 2008 | 4 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11837 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2008 | 14 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 263 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 731 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 151 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2008 | 160 | 0.020 |
Why?
|
| Amygdala | 1 | 2008 | 74 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 413 | 0.020 |
Why?
|
| Exocytosis | 1 | 2007 | 66 | 0.020 |
Why?
|
| Adiposity | 1 | 2008 | 208 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 170 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 419 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 1059 | 0.020 |
Why?
|
| Aggression | 1 | 2008 | 218 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 583 | 0.010 |
Why?
|
| Cell Movement | 1 | 2009 | 868 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 715 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2008 | 767 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 429 | 0.010 |
Why?
|
| Pain | 1 | 2008 | 428 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2008 | 708 | 0.010 |
Why?
|